2.

Methylation of the DLC1 promoter region in human cancers:solid tumours

Tumour type	Fraction of samples methylated	Percent methylated	Reference
Primary hepatocellular carcinomas	6/25	24	[40]
Hepatocellular carcinoma cell lines	3/7	43	[40]
Non-small cell carcinoma cell lines	10/19	53	[81]
Non-small cell carcinomas	11/18	61	[82]
Matching normal tissue	2/8	25	[82]
Non-small cell carcinoma cell lines	2/11	18	[82]
Gastric carcinomas	29/97	30	[33]
Gastric cancer cell lines	5/7	71	[33]
Prostate carcinomas	13/27	48	[85]
Matching normal tissue	2/27	7	[85]
Benign prostate hyperplasia	15/21	71	[85]
Normal prostate tissue	0/10	0	[85]
Breast carcinomas	5/14	36	[34]
Breast carcinoma cell lines	3/9	33	[34]
Breast carcinomas	4/39	10	[94]
Breast carcinoma cell lines	5/20	25	[94]
Nasopharyngeal carcinomas	31/39	79	[86]
Nasopharyngeal carcinomas	64/72	89	[34]
Nasopharyngeal carcinoma cell lines	11/12	91	[34]
Oesophageal carcinomas	48/94	51	[34]
Oesophageal carcinoma cell lines	6/15	40	[34]
Cervical carcinomas	7/8	87	[34]
Cervical carcinoma cell lines	5/8	63	[34]
Renal cell carcinomas	12/34	35	[95]
Matching normal tissue	1/34	3	[95]
Renal carcinoma cell lines	1/7	14	[95]